This on demand session explores how to maintain momentum in population PK modeling without compromising quality. See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve. The focus is on continuity, helping teams adapt to changing requirements while delivering consistent, high quality results.

Session highlights

Target mediated drug disposition

Kathleen Koeck, PhD
Director, Certara Drug Development Solutions

Compartmental population PK for a CNS therapy

Nathalie Gosselin, PhD
Vice President, Certara Drug Development Solutions

Ideal for:

• Quantitative Clinical Pharmacologists
• Early career pharmacometricians